Literature DB >> 23406209

Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with inflammatory bowel disease in the Tunisian population.

Dorra Bouzid1, Hajer Fourati, Ali Amouri, Isabel Marques, Olfa Abida, Samy Haddouk, Mourad Ben Ayed, Nabil Tahri, Carlos Penha-Gonçalves, Hatem Masmoudi.   

Abstract

Inflammatory bowel diseases (IBDs), consisting of ulcerative colitis (UC) and Crohn's disease (CD), are complex disorders with multiple genes contributing to disease pathogenesis. We aimed to identify the associations of genetic variations in the ZAP70, PTPN6, BANK1, and CLEC2D genes encoding for intracellular signaling molecules with IBDs. One hundred seven patients (39 CD and 68 UC) with IBD and 162 healthy control subjects from the Southern Tunisia were recruited. We genotyped 4 single-nucleotide polymorphisms (SNPs) in ZAP70 (rs1020396, rs11686881, rs13420683, and rs17695937), 2 SNPs in PTPN6 (rs7310161 and rs759052), 3 SNPs in BANK1 (rs10516487, rs17266594, and rs3733197), and 1 SNP in CLEC2D (rs3764021). ZAP70 displayed a strong genetic association with CD for rs13420683 [allele C, p=0.003, P(corr)=0.006, odds ratio (OR)=2.25 (1.32; 3.85); genotype CC, p=0.016, P(corr)=0.048, OR=2.57 (1.22; 5.41)]. However, in UC, a weak association with PTPN6 was observed [TT (p=0.01; P(corr)=0.03; OR=2.11 (1.18; 3.76)]. No significant association in the BANK1 and CLEC2D genes was observed. These results suggest the involvement of the ZAP70 and PTPN6 genes in the genetic component conferring a general susceptibility to CD and UC, respectively. This work provides motivation for studies aiming to replicate these findings in larger populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406209     DOI: 10.1089/gtmb.2012.0372

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  5 in total

Review 1.  Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

2.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

Review 3.  Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease.

Authors:  Kelly A Pike; Michel L Tremblay
Journal:  Front Immunol       Date:  2018-10-31       Impact factor: 7.561

4.  Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.

Authors:  Sander Bins; Edwin A Basak; Samira El Bouazzaoui; Stijn L W Koolen; E Oomen-de Hoop; Cor H van der Leest; Astrid A M van der Veldt; Stefan Sleijfer; Reno Debets; Ron H N van Schaik; Joachim G J V Aerts; Ron H J Mathijssen
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

5.  Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.

Authors:  Daan P Hurkmans; Edwin A Basak; Nina Schepers; Esther Oomen-De Hoop; Cor H Van der Leest; Samira El Bouazzaoui; Sander Bins; Stijn L W Koolen; Stefan Sleijfer; Astrid A M Van der Veldt; Reno Debets; Ron H N Van Schaik; Joachim G J V Aerts; Ron H J Mathijssen
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.